Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25
Swiss (SMI) Healthcare Sector Analysis
UpdatedApr 25, 2024
DataAggregated Company Financials
Companies34
- 7D2.6%
- 3M-1.0%
- 1Y-8.2%
- YTD-0.3%
In the last week, the Healthcare industry is up 3.3%, with Roche Holding up 3.7%. In contrast, the industry has lost 8.8% in the last 12 months. Earnings are forecast to grow by 12% annually.
Sector Valuation and Performance
Has the Swiss Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Apr 2024 | CHF537.6b | CHF146.2b | CHF22.9b | 35.3x | 23.5x | 3.7x |
| Sat, 23 Mar 2024 | CHF534.6b | CHF144.2b | CHF22.2b | 37.5x | 24x | 3.7x |
| Mon, 19 Feb 2024 | CHF520.7b | CHF142.8b | CHF22.4b | 32.9x | 23.3x | 3.6x |
| Wed, 17 Jan 2024 | CHF544.3b | CHF152.1b | CHF21.9b | 27.3x | 24.9x | 3.6x |
| Fri, 15 Dec 2023 | CHF524.3b | CHF152.2b | CHF21.9b | 27.1x | 24x | 3.4x |
| Sun, 12 Nov 2023 | CHF502.6b | CHF155.0b | CHF22.2b | 23.4x | 22.7x | 3.2x |
| Tue, 10 Oct 2023 | CHF532.7b | CHF154.2b | CHF21.7b | 28.2x | 24.5x | 3.5x |
| Thu, 07 Sep 2023 | CHF535.2b | CHF144.7b | CHF21.2b | 30x | 25.3x | 3.7x |
| Sat, 05 Aug 2023 | CHF549.4b | CHF146.5b | CHF22.5b | 35.3x | 24.4x | 3.8x |
| Mon, 03 Jul 2023 | CHF565.9b | CHF147.1b | CHF22.2b | 35.6x | 25.5x | 3.8x |
| Wed, 31 May 2023 | CHF571.6b | CHF147.7b | CHF22.3b | 34.7x | 25.6x | 3.9x |
| Fri, 28 Apr 2023 | CHF568.7b | CHF147.0b | CHF22.4b | 32x | 25.4x | 3.9x |
| Sun, 26 Mar 2023 | CHF528.4b | CHF148.0b | CHF22.5b | 36.3x | 23.5x | 3.6x |
| Tue, 21 Feb 2023 | CHF548.4b | CHF147.8b | CHF22.7b | 32.5x | 24.1x | 3.7x |
| Thu, 19 Jan 2023 | CHF573.2b | CHF147.8b | CHF37.8b | 32.5x | 15.2x | 3.9x |
| Sat, 17 Dec 2022 | CHF565.9b | CHF148.9b | CHF38.2b | 30.4x | 14.8x | 3.8x |
| Mon, 14 Nov 2022 | CHF584.0b | CHF149.5b | CHF38.4b | 30.8x | 15.2x | 3.9x |
| Wed, 12 Oct 2022 | CHF562.6b | CHF153.1b | CHF40.7b | 26.7x | 13.8x | 3.7x |
| Fri, 09 Sep 2022 | CHF582.4b | CHF151.4b | CHF40.1b | 25.7x | 14.5x | 3.8x |
| Sun, 07 Aug 2022 | CHF600.8b | CHF150.2b | CHF39.9b | 31.6x | 15.1x | 4x |
| Tue, 05 Jul 2022 | CHF590.6b | CHF148.7b | CHF40.4b | 30.2x | 14.6x | 4x |
| Thu, 02 Jun 2022 | CHF608.0b | CHF148.9b | CHF40.4b | 31.1x | 15x | 4.1x |
| Sat, 30 Apr 2022 | CHF647.2b | CHF148.8b | CHF40.4b | 37.4x | 16x | 4.4x |
| Mon, 28 Mar 2022 | CHF658.0b | CHF145.7b | CHF39.2b | 39.7x | 16.8x | 4.5x |
| Wed, 23 Feb 2022 | CHF627.1b | CHF144.5b | CHF38.9b | 40x | 16.1x | 4.3x |
| Fri, 21 Jan 2022 | CHF662.0b | CHF139.0b | CHF25.1b | 47.7x | 26.3x | 4.8x |
| Sun, 19 Dec 2021 | CHF685.1b | CHF139.3b | CHF25.2b | 46x | 27.2x | 4.9x |
| Tue, 16 Nov 2021 | CHF693.1b | CHF138.3b | CHF25.1b | 48.9x | 27.6x | 5x |
| Thu, 14 Oct 2021 | CHF675.8b | CHF137.6b | CHF24.3b | 46.3x | 27.8x | 4.9x |
| Sat, 11 Sep 2021 | CHF677.9b | CHF137.5b | CHF24.3b | 49.8x | 27.9x | 4.9x |
| Mon, 09 Aug 2021 | CHF707.1b | CHF137.4b | CHF24.2b | 54.5x | 29.2x | 5.1x |
| Sun, 02 May 2021 | CHF592.4b | CHF134.7b | CHF22.9b | 51.2x | 25.8x | 4.4x |
Price to Earnings Ratio
25.8x
Current Industry PE
- Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.2x.
- The industry is trading close to its 3-year average PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 2.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare sector?
| CH Market | 1.05% | |
| Healthcare | 2.57% | |
| Pharma | 3.26% | |
| Medical Equipment | 1.04% | |
| Life Sciences | 0.43% | |
| Healthcare Services | 0.16% | |
| Healthtech | -6.68% | |
| Biotech | -10.39% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 51.2x.
- Analysts are expecting annual earnings growth of 18.3%, which is higher than its past year's earnings growth of 6.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 18% over the next 5 years.
- This is better than its past earnings growth rate of 6.5% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 7.2% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROG Roche Holding | CHF222.20 | 1.0% +CHF1.7b | -19.1% | PE15.4x | |
| SDZ Sandoz Group | CHF30.61 | 9.1% +CHF1.1b | n/a | PE186.7x | |
| GALD Galderma Group | CHF66.49 | 5.5% +CHF825.5m | n/a | n/a | |
| ALC Alcon | CHF72.80 | 1.1% +CHF394.6m | 13.6% | PE40.3x | |
| SOON Sonova Holding | CHF255.20 | 2.3% +CHF339.9m | -8.5% | PE25.3x |
